PRLD - Prelude Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRLD is currently covered by 3 analysts with an average price target of $2.43. This is a potential upside of $0.99 (68.75%) from yesterday's end of day stock price of $1.44.

Prelude Therapeutics 's activity chart (see below) currently has 42 price targets and 41 ratings on display. The stock rating distribution of PRLD is 90% BUY and 10% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 31.96% with an average time for these price targets to be met of 58.8 days.

Highest price target for PRLD is $5, Lowest price target is $1, average price target is $3.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 23-Sep-2025. First documented stock forecast 20-Oct-2020.

Best performing analysts who are covering PRLD - Prelude Therapeutics :

Tazeen Ahmad Robert Burns Jeffrey Hung Peter Lawson Reni Benjamin

Currently out of the existing stock ratings of PRLD, 9 are a BUY (90%), 1 are a SELL (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$5

$3.53 (240.14%)

$5

14 days ago
(23-Sep-2025)

5/16 (31.25%)

$3.97 (385.44%)

100

Buy

$3

$1.53 (104.08%)

$4

1 months 19 days ago
(18-Aug-2025)

0/6 (0%)

$2.06 (219.15%)

Sell

$1

$-0.47 (-31.97%)

11 months 9 days ago
(28-Oct-2024)

2/5 (40%)

$-0.5 (-33.33%)

136

Sell

$4

$2.53 (172.11%)

$10

1 years 9 months 18 days ago
(19-Dec-2023)

2/7 (28.57%)

$-0.04 (-0.99%)

4

Hold

$6

$4.53 (308.16%)

$10

2 years 10 months 16 days ago
(21-Nov-2022)

3/5 (60%)

$-0.53 (-8.12%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRLD (Prelude Therapeutics ) average time for price targets to be met?

On average it took 58.8 days on average for the stock forecasts to be realized with a an average price target met ratio 31.96

Which analyst has the current highest performing score on PRLD (Prelude Therapeutics ) with a proven track record?

TAZEEN AHMAD

Which analyst has the current lower performing score on PRLD (Prelude Therapeutics ) with a proven track record?

RENI BENJAMIN

Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?

Tazeen Ahmad works at BAML and has 25 price targets and 16 ratings on PRLD

Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?

Tazeen Ahmad with highest potential upside - $4.53

Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?

Peter Lawson with lowest potential downside - -$0.47

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?